What one share of Fennec Pharmaceuticals holds
The following is a summary of the principal risks that could adversely affect our business, operations, and financial results. A more thorough discussion of these and other risks follows this summary.
Fennec Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.77 |
|---|---|
| Profit | −$0.10 |
| Cash and investments | $1.18 |
| Debt | $0.55 |
| Book value | $1.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$1.47 | — | — | — | −$0.72 |
| 2011 | $0.00 | $0.59 | $0.00 | −$0.40 | — | −$0.01 |
| 2012 | $0.00 | −$0.62 | $0.00 | −$0.36 | — | −$0.59 |
| 2013 | $0.00 | $0.17 | $0.00 | −$0.21 | — | −$0.15 |
| 2014 | $0.00 | −$0.22 | — | — | — | $0.06 |
| 2015 | $0.00 | −$0.06 | — | — | — | $0.05 |
| 2016 | $0.00 | −$0.22 | — | — | — | $0.26 |
| 2017 | $0.00 | −$0.47 | — | — | — | $1.45 |
| 2018 | $0.00 | −$0.52 | — | — | — | $1.07 |
| 2019 | $0.00 | −$0.64 | — | — | — | $0.60 |
| 2020 | $0.01 | −$0.76 | — | — | — | $1.12 |
| 2021 | — | −$0.67 | — | — | — | $0.61 |
| 2022 | $0.06 | −$0.90 | — | — | — | −$0.10 |
| 2023 | $0.80 | −$0.60 | — | — | — | −$0.43 |
| 2024 | $1.74 | −$0.02 | — | — | — | −$0.21 |
| 2025 | $1.56 | −$0.34 | — | — | — | $1.04 |
Common questions about Fennec Pharmaceuticals
How much does one share of Fennec Pharmaceuticals earn?
Over the last 12 months, Fennec Pharmaceuticals lost $0.10 for each share on $1.77 of sales.
Does Fennec Pharmaceuticals pay a dividend?
Fennec Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Fennec Pharmaceuticals’s book value per share?
Fennec Pharmaceuticals’s book value is $1.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Fennec Pharmaceuticals have?
Each share of Fennec Pharmaceuticals has $1.18 of cash and investments and $0.55 of debt, as of June 30, 2026.
Has Fennec Pharmaceuticals bought back shares?
Fennec Pharmaceuticals’s share count rose about 435% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.